New laws seek to end ‘doctor shopping,’ prevent opioid abuse

Seeking to make greater use of their states’ prescription drug monitoring programs and to prevent opioid abuse, Illinois and Michigan lawmakers have established new requirements for prescribers. These measures were signed into law in December.

Under Illinois’ SB 772, a patient’s prescription history must be checked, via the state-run program’s database, before he or she is prescribed Schedule II narcotics. This is the federal classification for drugs that have a “high potential for abuse.” Michigan providers will have to review a patient’s history in the state-run electronic database before prescribing Schedule II, III, IV or V controlled substances (SB 166 and 167). One goal of these mandatory checks is to make it harder for individuals to obtain prescriptions from multiple doctors.
Every Midwestern state has a prescription monitoring program. Ohio and North Dakota require, under certain circumstances, prescribers and dispensers to check a patient’s history in the database, according to the Prescription Drug Monitoring Program Training and Technical Assistance Center. This mandate only applies to prescribers in Illinois, Indiana, Michigan, Minnesota and Wisconsin. Other states have no such requirements on prescribers or dispensers.
AttachmentSize
Stateline Midwest: January 20182.48 MB